News

Embark on the journey to explore new markets with Neocrema.

News

Embark on the journey to explore new markets with Neocrema.

News

Embark on the journey to explore new markets with Neocrema.

NeoCrema Co., Ltd. has signed a technology transfer agreement with Yeungnam University for the 'Prevention or Treatment of Muscle Diseases Using Licorice Extract'.

NeoCrema Co., Ltd. has signed a technology transfer agreement with Yeungnam University for the 'Prevention or Treatment of Muscle Diseases Using Licorice Extract'.

Neo Crema Co., Ltd. has entered into a patent technology transfer agreement today (April 29) for 'a composition for the prevention or treatment of muscular diseases containing licorice extract as an active ingredient', developed by Professor Choi In-ho's team at Yeungnam University School of Life Sciences and Biotechnology.

In addition to five other technologies.

Utilizing the technology transferred through this agreement, we can expect effective prevention, improvement, and treatment of muscular diseases, leveraging natural substances with ingestion history.

This enables us to develop safe products for muscular disease prevention without side effects.